Your trusted brain health platform for early detection

Linus Health’s AI-driven brain health platform equips payers with the information they need to detect cognitive impairment early and monitor members over time.

Healthcare executives working on computer in the office

Did you know 77% of health plans recognize dementia as a growing crisis, but only 4% have a strategy in place to address it?

Our brain health platform bridges the gap and helps payers mitigate the financial burden associated with late-stage care. Linus Health is here to:

  • Identify and detect early: Identifying those at-risk through AI-driven analysis to help improve outcomes and lowering long-term costs.
  • Enable proactive care: Continual monitoring detects decline early, guiding members through the care planning process and assisting in late-stage interventions.
  • Seamless implementation: Our platform seamlessly integrates into payer systems via low-code APIs for a disruption-free adoption

payers2
Download our whitepaper to learn more about our collaboration with payers for early detection of cognitive impairment.

Download our report

Frequently asked questions

Below you'll find answers to the most common questions about cognitive assessments.

How does Linus Health’s involvement in clinical trials support payer confidence?

Linus Health’s platform has been used in 60+ clinical trials, demonstrating its scientific rigor and reliability in regulated environments. This track record reinforces the clinical accuracy of our tools, giving payers confidence in their use for risk stratification, early detection, and diagnostic support.

Is the platform accessible on multiple devices across diverse member populations?

Yes. Our tools support multiple languages and can be deployed on any standard device (desktop, laptop, tablet, phone, etc.), helping expand access and promote health equity across linguistically and culturally diverse populations.

What is cognitive testing?

Cognitive testing focuses on assessing an individual’s cognition to determine if their cognitive performance is normal or if they may have signs of cognitive impairment. Signs of cognitive impairment can be present even if an individual is not exhibiting clinical symptoms. Some cognitive impairment cases stem from reversible causes, but others may occur due to underlying causes like Alzheimer’s disease or other dementia. Cognitive testing is particularly important for older adults and assessing patients for cognitive impairment is now a required part of Medicare’s Annual Wellness Visit. 

What are the most common cognitive function tests?

The most commonly used cognitive assessments historically have been paper-based cognitive tests, such as the Mini-Mental State Exam (MMSE) and Montreal Cognitive Assessment for Dementia (MoCA), described above, though a variety of other tests exist. Digital cognitive assessments have also arisen in recent years and are rising in usage. Patients experiencing clinical symptoms of cognitive impairment may also undergo more elaborate neurocognitive testing with a combination of tests to further a diagnosis and care plan.

Why would providers choose to use a digital cognitive test instead of paper-based tests?

Digital cognitive assessments offer a wide range of benefits over paper-based cognitive assessments. For example, digital cognitive testing solutions boost workflow efficiency with automated administration and scoring. They also enable objectivity and consistency in cognitive testing and some have shown to have higher sensitivity than traditional tests.